| (a) | Amount beneficially owned: The ownership percentages set forth below calculated pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended (“Rule 13d-3”), are based on 14,257,599 shares of Class A Common Stock outstanding as of October 26, 2015, as reported in the Form 10-Q of the Issuer, filed with the Securities and Exchange Commission on October 30, 2015, plus the number of shares of Class A Common Stock that may be received upon exchange of limited liability company units of Adeptus Health LLC (“Units of Adeptus Health LLC”) beneficially owned by the Reporting Person. 5-N Investments, LLC beneficially owns 1,447,778 shares of Class A Common Stock (based on the number of shares of Class A Common Stock that may be received in exchange of Units of Adeptus Health LLC held by 5-N Investments, LLC), which represents 9.2% of the total number of shares of Class A Common Stock outstanding calculated pursuant to Rule 13d-3. Dr. Jacob John Novak, as the manager of 5-N Investments, LLC, may be deemed to beneficially own 1,447,778 shares of Class A Common Stock (based on the number of shares of Class A Common Stock that may be received in exchange of Units of Adeptus Health LLC held by the 5-N Investments, LLC), which represents 9.2% of the total number of shares of Class A Common Stock outstanding calculated pursuant to Rule 13d-3. On a fully diluted basis, the Reporting Persons may be deemed, in the aggregate, to be the beneficial owners of 7.0% of the outstanding Class A Common Stock, based on 14,257,599 shares of Class A Common Stock and 6,510,738 shares of Class B common stock, par value $0.01 per share, and an equal number of Units of Adeptus Health LLC outstanding as of October 26, 2015. |